查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529715

诱导性多功能干细胞生产市场规模、份额、趋势分析报告：按製程、按工作流程、按产品、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

诱导性多功能干细胞生产市场的成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球诱导性多功能干细胞生产市场规模将达到27.6亿美元，2024年至2030年复合年增长率为9.44%。

与胚胎干细胞（ESC）相比，诱导性多功能干细胞（iPSC）的需求不断增长，显着推动了市场的发展。干细胞不存在伦理问题、个人化治疗的可能性以及细胞研究的灵活性等优势为市场成长创造了有利的前景。此外，慢性病的流行也推动了诱导性多功能干细胞生产市场的成长。这是因为心臟病、中风、糖尿病和许多其他疾病都可以使用 iPS 细胞介导的疗法来治疗。例如，根据国际糖尿病联盟 (IDF) 的数据，到 2021 年，将有 5.37 亿人患有糖尿病。

COVID-19 大流行期间研究活动的增加对市场产生了积极影响。由于 SARS CoV-2 感染已导致患者患有多种疾病，此次疫情大流行促进了许多领域的研究。例如，2021年4月，美国研究人员表示，高达25%的COVID-19患者患有心臟功能障碍。透过他们的研究论文，他们证明这种疾病是由 iPS 细胞衍生的心臟细胞暴露于 SARS CoV-2 引起的，并且在患者的人体尸检标本中也证实了类似的变化。这些见解使得能够使用诱导性多功能干细胞(iPSC) 作为开发药物和治疗方法的平台，以控制 COVID-19 的长期影响。

诱导性多功能干细胞是源自成体细胞的细胞，并进一步重新编程以获得类似 ESC 的多功能。事实证明，这些 iPS 细胞对于使用 ESC 进行研究来说是一个在伦理上合理的选择。伦理争论最激烈，因为胚胎干细胞的产生涉及破坏胚囊阶段的胚胎。然而，诱导性多功能干细胞仅透过对体细胞进行基因重编程，就解决了研究中破坏人类胚胎的伦理问题。这推动了市场成长，并带来了药物发现、疾病建模和毒性测试等众多应用。例如，2021年8月，Fate Therapeutics宣布临床试验中首例FT819患者接受治疗。 FT819是一种源自iPS细胞的人工CAR-T细胞疗法。由于其独特的特性，如可再生潜力、自我更新潜力和免疫调节特性，研究界越来越关注探索诱导性多功能干细胞在再生医学中的应用，从而推动了市场的扩张。

诱导性多功能干细胞生产市场报告亮点

  • 从製程来看，手动 iPSC 生产流程占据市场主导地位，并在 2023 年占据最大的收益占有率。
  • 从工作流程来看，细胞培养细分市场占据主导地位，2023 年收益占有率最大，为 37.34%。细胞培养工作流程包括来自 iPSC 收穫产品、扩增产品和分化产品的收益，有助于提高该细分市场的市场相关性。
  • 按产品划分，耗材和套件细分市场占据主导地位，2023 年收益占有率最大，为 40.32%。 iPSC 领域的持续研发活动正在推动对各种耗材和套件的需求。
  • 从应用来看，药物开发和发现领域占据市场主导地位，2023 年销售额份额最大，为 43.33%。
  • 以最终用途划分，生物技术和製药公司细分市场占据主导地位，2023 年收益占有率最高，达 59.35%。各种套件、耗材和仪器以及 iPSC 产品的可用性和采用正在推动该领域的产生收入。
  • 北美地区主导市场，2023 年收益占有率最大，为 40.98%。该地区慢性病患病率的上升、发达的医疗基础设施、私人和政府倡议的资金以及战略经营模式正在推动该市场的产生收入。

目录

第一章调查方法和范围

第二章执行概述

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章诱导性多功能干细胞生产市场：流程业务分析

  • 技术细分仪表板
  • 全球诱导性多功能干细胞生产市场流程及波动分析
  • 2018-2030年全球诱导性多功能干细胞生产市场规模及趋势分析（依製程）
  • 手动 iPSC 生产流程
  • 自动化 iPSC 生产流程

第五章诱导性多功能干细胞生产市场：工作流程业务分析

  • 工作流程细分仪表板
  • 全球诱导性多功能干细胞生产市场的流程变化分析
  • 2018-2030年全球诱导性多功能干细胞生产市场规模及趋势分析（依工作流程）
  • 重新程式设计
  • 细胞培养
  • 细胞表征/分析
  • 工程
  • 其他的

第六章诱导性多功能干细胞生产市场：产品业务分析

  • 产品细分仪表板
  • 全球诱导性多功能干细胞生产市场产品波动分析
  • 2018-2030年全球诱导性多功能干细胞生产市场规模及趋势分析（分产品）
  • 设备/设备
  • 自动化平台
  • 耗材和套件
  • 服务

第七章诱导性多功能干细胞生产市场：应用业务分析

  • 范例类型细分仪表板
  • 全球诱导性多功能干细胞生产市场应用变化分析
  • 2018-2030年全球诱导性多功能干细胞生产市场规模及趋势分析（依应用）
  • 药物开发和发现
  • 再生医学
  • 毒理学研究
  • 其他的

第八章诱导性多功能干细胞生产市场：最终用途业务分析

  • 最终用途细分仪表板
  • 全球诱导性多功能干细胞生产市场的最终用途变化分析
  • 2018-2030年全球诱导性多功能干细胞生产市场规模与趋势分析（依最终用途）
  • 研究/学术机构
  • 生物技术和製药公司
  • 医院/诊所

第九章诱导性多功能干细胞生产市场：按流程、工作流程、产品、应用和最终用途进行区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • Lonza
    • Axol Bioscience Ltd.
    • Evotec
    • REPROCELL Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • Catalent, Inc
    • Applied StemCells, Inc.

第十一章分析师的观点

Product Code: GVR-4-68039-549-7

Induced Pluripotent Stem Cells Production Market Growth & Trends:

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights:

  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.
  • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Process
    • 1.2.2. Workflow
    • 1.2.3. Product
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing applications of regenerative medicine
      • 3.2.1.2. Technological advancements in ipsc production
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control and regulatory challenges
      • 3.2.2.2. High cost of production
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Induced Pluripotent Stem Cells Production Market: Process Business Analysis

  • 4.1. Technology Segment Dashboard
  • 4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis
  • 4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
  • 4.4. Manual iPSC Production Process
    • 4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Automated iPSC Production Process
    • 4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production Market: Workflow Business Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis
  • 5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Reprogramming
    • 5.4.1. Global Reprogramming Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cell Culture
    • 5.5.1. Global Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cell Characterization/Analysis
    • 5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Engineering
    • 5.7.1. Global EngineeringMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production Market: Product Business Analysis

  • 6.1. Product Segment Dashboard
  • 6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis
  • 6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Instrument/Devices
    • 6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Automated Platforms
    • 6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Consumables & Kits
    • 6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Media
      • 6.6.2.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Kits
      • 6.6.3.1. Global Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Others
      • 6.6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Services
    • 6.7.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production Market: Application Business Analysis

  • 7.1. Sample Type Segment Dashboard
  • 7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis
  • 7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Drug Development and Discovery
    • 7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Regenerative Medicine
    • 7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Toxicology Studies
    • 7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production Market: End Use Business Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis
  • 8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Research & Academic Institutes
    • 8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Biotechnology & Pharmaceutical Companies
    • 8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Hospitals & Clinics
    • 8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production Market: Regional Estimates & Trend Analysis by Process, Workflow, Product, Application, & End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Participant's Overview
    • 10.4.1. Lonza
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Axol Bioscience Ltd.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Evotec
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. REPROCELL Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. STEMCELL Technologies
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Merck KGaA
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Fate Therapeutics
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Thermo Fisher Scientific, Inc.
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Catalent, Inc
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Applied StemCells, Inc.
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

Chapter 11. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 5 Global induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 12 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 16 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 21 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 22 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 26 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 28 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 29 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 32 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 33 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 35 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 37 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 38 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 40 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 42 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 43 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 45 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 47 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 48 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 50 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 52 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 53 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 55 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 57 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 58 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 60 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 62 Denmark induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 67 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 70 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 72 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 73 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 75 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 83 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 84 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 88 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 89 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 91 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 93 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 94 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 96 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 98 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 99 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 101 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 103 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 106 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 108 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 114 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 117 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 119 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 122 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 124 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 135 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 145 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 146 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Induced pluripotent stem cells production market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Induced pluripotent stem cells production market driver analysis
  • Fig. 12 Induced pluripotent stem cells production market restraint analysis
  • Fig. 13 Induced pluripotent stem cells production market: Porter's analysis
  • Fig. 14 Induced pluripotent stem cells production market: PESTEL analysis
  • Fig. 15 Induced pluripotent stem cells production market: Product outlook and key takeaways
  • Fig. 16 Induced pluripotent stem cells production market: Product market share analysis, 2023 - 2030
  • Fig. 17 Global induced pluripotent stem cells production by instruments/devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global induced pluripotent stem cells production by automated platforms market, 2018 - 2030 (USD Million)
  • Fig. 19 Global induced pluripotent stem cells production by consumables & kits market, 2018 - 2030 (USD Million)
  • Fig. 20 Global induced pluripotent stem cells production by kits market, 2018 - 2030 (USD Million)
  • Fig. 21 Global induced pluripotent stem cells production by media market, 2018 - 2030 (USD Million)
  • Fig. 22 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global induced pluripotent stem cells production by services market, 2018 - 2030 (USD Million)
  • Fig. 24 Induced pluripotent stem cells production market: Process outlook and key takeaways
  • Fig. 25 Induced pluripotent stem cells production market: Process market share analysis, 2023 - 2030
  • Fig. 26 Global induced pluripotent stem cells production by manual iPSC production process market, 2018 - 2030 (USD Million)
  • Fig. 27 Global induced pluripotent stem cells production by automated iPSC production process market, 2018 - 2030 (USD Million)
  • Fig. 28 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
  • Fig. 29 Induced pluripotent stem cells production market: Workflow market share analysis, 2023 - 2030
  • Fig. 30 Global induced pluripotent stem cells production by reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 31 Global induced pluripotent stem cells production by cell culture market, 2018 - 2030 (USD Million)
  • Fig. 32 Global induced pluripotent stem cells production by cell characterization/analysis market, 2018 - 2030 (USD Million)
  • Fig. 33 Global induced pluripotent stem cells production by engineering market, 2018 - 2030 (USD Million)
  • Fig. 34 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 35 Induced pluripotent stem cells production market: Application outlook and key takeaways
  • Fig. 36 Induced pluripotent stem cells production market: Application market share analysis, 2023 - 2030
  • Fig. 37 Global induced pluripotent stem cells production by drug development & discovery market, 2018 - 2030 (USD Million)
  • Fig. 38 Global induced pluripotent stem cells production by regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 39 Global induced pluripotent stem cells production by toxicology studies market, 2018 - 2030 (USD Million)
  • Fig. 40 Global induced pluripotent stem cells production by others market, 2018 - 2030 (USD Million)
  • Fig. 41 Induced pluripotent stem cells production market: End use outlook and key takeaways
  • Fig. 42 Induced pluripotent stem cells production market: End use market share analysis, 2023 - 2030
  • Fig. 43 Global induced pluripotent stem cells production by research & academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 44 Global induced pluripotent stem cells production by biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 45 Global induced pluripotent stem cells production by hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada induced pluripotent stem cells production market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Europe induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 France induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Norway induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Asia-Pacific induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Japan induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 China induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 India induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Australia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait induced pluripotent stem cells production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Key company categorization
  • Fig. 76 Company market positioning
  • Fig. 77 Market participant categorization
  • Fig. 78 Strategy framework